Colorectal Cancer Treatment Market Size & Forecast by 2030
Perspectivas del mercado y vista de analista:
El creciente tamaño del mercado se atribuye al creciente número de casos de cáncer colorrectal y al aumento de las aprobaciones de terapias dirigidas e inmunoterapia para tratar el cáncer colorrectal. Además, las iniciativas estratégicas de las empresas para seguir siendo competitivas en el mercado están impulsando el crecimiento del mercado. Es probable que un aumento significativo en los medicamentos personalizados para abordar las necesidades de los clientes para el tratamiento del cáncer colorrectal traiga nuevas tendencias en el mercado de tratamiento del cáncer colorrectal durante el período de pronóstico.
Impulsores de crecimiento y desafíos:
El cáncer colorrectal es un tumor maligno que se presenta en tejidos del colon o del recto. Factores del estilo de vida como la baja ingesta de frutas y verduras, la adicción al tabaco, el sedentarismo, la obesidad, el alto consumo de carnes procesadas y el consumo excesivo de alcohol están contribuyendo al crecimiento de los casos de cáncer colorrectal. Es el tercer tipo de cáncer más común (excluyendo el cáncer de piel) diagnosticado anualmente en los EE. UU. En 2023, la Organización Mundial de la Salud (OMS) afirmó que el cáncer colorrectal es el tercer cáncer más común en todo el mundo y la segunda causa principal de muertes relacionadas con el cáncer a nivel mundial. Según la misma fuente, alrededor del 10% del total de casos diagnosticados a nivel mundial son casos de cáncer colorrectal. Según las estimaciones de la Sociedad Estadounidense del Cáncer, en 2023 se registraron en los EE. UU. alrededor de 106 000 nuevos casos de cáncer de colon y ~46 000 nuevos casos de cáncer de recto.
Según los datos proporcionados por el Sistema Europeo de Información sobre el Cáncer, el cáncer colorrectal representó aproximadamente 12,7 El % de todos los nuevos cánceres diagnosticados en 2020 y aproximadamente el 12,4 % de las mortalidades totales fueron causados por cáncer colorrectal en 2020 en los países de la UE-27. Debido a esta alta prevalencia, el cáncer colorrectal es el segundo cáncer más frecuente, después del cáncer de mama, y la segunda causa de muerte relacionada con el cáncer, después del cáncer de pulmón. Según la Agencia Internacional para la Investigación del Cáncer y GLOBOCAN, en 2020 se notificaron ~1 millón de nuevos casos de cáncer colorrectal en Asia. Japón, Malasia, China, Singapur, Turquía y Corea registraron altas tasas de prevalencia en comparación con otros países de Asia. Pacífico. Además, para 2040, se estima que la carga mundial de cáncer colorrectal aumentará en un 72% a más de 3 millones de casos nuevos, lo que representa una grave amenaza para la salud humana. Por lo tanto, la creciente incidencia del cáncer colorrectal impulsa el crecimiento del mercado de tratamiento del cáncer colorrectal.
Segmentación y alcance del informe:
El análisis del mercado de tratamiento del cáncer colorrectal se ha llevado a cabo considerando los siguientes segmentos: tipo de tratamiento , grupo de edad, usuario final y geografía. El mercado del tratamiento del cáncer colorrectal, por tipo de tratamiento, se segmenta en cirugía, quimioterapia, terapia dirigida, inmunoterapia y otros. Según el grupo de edad, el mercado se divide en menores de 49 años, entre 50 y 64 años y mayores de 65 años. El mercado, por usuario final, se segmenta en hospitales, clínicas especializadas, atención domiciliaria y otros. El alcance del informe de mercado del tratamiento del cáncer colorrectal incluye América del Norte (EE. UU., Canadá y México), Europa (España, Reino Unido, Alemania, Francia, Italia y el resto de Europa), Asia Pacífico (Corea del Sur, China, Japón, India, Australia y el resto de Asia Pacífico), Medio Oriente y África (Sudáfrica, Arabia Saudita, Emiratos Árabes Unidos y el resto de Medio Oriente y África) y América del Sur y Central (Brasil, Argentina y el resto de Asia Pacífico). Resto de América Central y del Sur).
Análisis segmentario:
El mercado de tratamiento del cáncer colorrectal, por tipo de tratamiento, se segmenta en cirugía, quimioterapia, terapia dirigida, inmunoterapia y otros. En 2022, el segmento de cirugía tuvo la mayor participación de mercado en el tratamiento del cáncer colorrectal y se espera que registre la CAGR más alta durante 2022-2030. La cirugía se considera el tratamiento más común para todas las etapas del cáncer colorrectal. Si el cáncer se diagnostica en las primeras etapas, se realizan procedimientos quirúrgicos para extirpar el tumor. Según el grupo de edad, el mercado se segmenta en menores de 49 años, 50 a 64 años y mayores de 65 años. En 2022, el segmento de 65 años mencionado anteriormente tuvo la mayor participación de mercado en el tratamiento del cáncer colorrectal y se proyecta que registre la CAGR más alta durante 2022-2030. Según un informe de la Sociedad Estadounidense del Cáncer, se estima que más de la mitad de los nuevos casos diagnosticados en los EE. UU. tienen más de 65 años, y más de dos tercios de todas las muertes por cáncer colorrectal se informaron entre personas mayores de 65 años. br>Según el usuario final, el mercado se divide en hospitales, clínicas especializadas, atención domiciliaria y otros. Es probable que el tamaño del mercado de tratamiento del cáncer colorrectal para el segmento hospitalario aumente durante 2022-2030.
Mercado de tratamiento del cáncer colorrectal, por tipo de tratamiento: 2022 y 2030
Análisis regional:
América del Norte es el mayor contribuyente a el crecimiento del mercado mundial del tratamiento del cáncer colorrectal. Se prevé que Asia Pacífico muestre la CAGR más alta del mercado durante 2022-2030. América del Norte ocupó la mayor participación del mercado global en 2022 debido al creciente número de cánceres colorrectales, los crecientes avances tecnológicos, la alta prevalencia de cáncer colorrectal en personas menores de 50 años y la presencia de actores clave del mercado involucrados en el desarrollo de productos nuevos y existentes. En América del Norte, EE. UU. tenía la mayor participación de mercado en 2022.
Desarrollos de la industria y oportunidades futuras:
El pronóstico del mercado de tratamiento del cáncer colorrectal se estima sobre la base de varios hallazgos de investigación primaria y secundaria, como la empresa clave. publicaciones, datos de asociaciones y bases de datos. Las estrategias de los actores clave que operan en el mercado del tratamiento del cáncer colorrectal se enumeran a continuación:
•En noviembre de 2023, Takeda Pharmaceutical anunció que había recibido la aprobación de la Administración de Medicamentos y Alimentos de EE. UU. (FDA) para su terapia oral dirigida FRUZAQLA ( fruquintinib) para tratar adultos que padecen cáncer colorrectal metastásico (CCRm). FRUZAQLA es el primer y único inhibidor selectivo de las tres quinasas receptoras de VEGF aprobado previamente en los EE. UU. para el tratamiento del CCRm, independientemente del estado del biomarcador. En agosto de 2023, Taiho Pharmaceutical Co., Ltd. anunció que la FDA de EE. UU. había aprobado LONSURF. (trifluridina/tipiracilo) como agente único y en combinación con bevacizumab para el tratamiento de pacientes adultos que padecen CCRm. Estos pacientes son tratados previamente con quimioterapia basada en oxaliplatino, fluoropirimidina e irinotecán, una terapia biológica anti-VEGF. Panorama competitivo y empresas clave:
Genentech Inc, Eli Lilly and Company, Pfizer Inc, Takeda Pharmaceuticals, Bristol Myers Squibb, Merck, Bayer AG, Regeneron Pharmaceuticals Inc, Novartis AG e Ipsen Biopharmaceuticals Inc se encuentran entre los actores destacados perfilados en el informe del mercado del tratamiento del cáncer colorrectal. Además, durante el estudio se han estudiado y analizado varios otros actores para obtener una visión holística del mercado y su ecosistema. Estas empresas se centran en expansiones geográficas y lanzamientos de nuevos productos para satisfacer la creciente demanda de los consumidores de todo el mundo y aumentar su gama de productos en carteras especializadas. Su presencia global les permite atender a una gran base de clientes, lo que posteriormente facilita la expansión del mercado.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The colorectal cancer treatment market majorly consists of the players such Genentech Inc, Eli Lilly and Company, Pfizer Inc, Takeda Pharmaceuticals, Bristol Myers Squibb, Merck, Bayer AG, Regeneron Pharmaceuticals Inc, Novartis AG, and Ipsen Biopharmaceuticals Inc.
Based on geography, the colorectal cancer treatment market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global colorectal cancer treatment market. Asia Pacific is expected to register the highest CAGR in the colorectal cancer treatment market during 2022–2030.
Colorectal cancer often begins as a growth called a polyp inside the colon or rectum. Colorectal cancer happens when there are changes in genetic material (DNA). These changes are also called mutations or variants. Often, the genetic changes that lead to colorectal cancer happen during lifetime and the exact cause is unknown. Colorectal cancer treatment includes surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, cryosurgery, and radiofrequency ablation.
The growing number of colorectal cancer cases and the subsequent increase in product launches are factors predominantly driving the colorectal cancer treatment market size. However, the high cost associated with colorectal cancer treatment in developing countries hinders the market growth.
The colorectal cancer treatment market, by treatment type, is segmented into surgery, chemotherapy, targeted therapy, immunotherapy, and others. In 2022, the surgery segment held the largest colorectal cancer treatment market share and is expected to record the highest CAGR during 2022–2030.
Based on age group, the market is segmented into below 49 years, 50–64 years, and above 65 years. In 2022, the above 65 years segment held the largest colorectal cancer treatment market share and is projected to record the highest CAGR during 2022–2030.
Based on end user, the market is divided into hospitals, specialty clinics, home care, and others. The colorectal cancer treatment market size for the hospital segment is likely to surge during 2022–2030.
The List of Companies - Colorectal Cancer Treatment Market
- Genentech Inc
- Eli Lilly and Company
- Pfizer Inc
- Takeda Pharmaceuticals
- Bristol Myers Squibb
- Merck
- Bayer AG
- Regeneron Pharmaceuticals Inc
- Novartis AG
- Ipsen Biopharmaceuticals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Feb 2024
Smart Hospital Beds Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Patient Weight (Less than 70 lb, 70 to 150 lb, 150 to 400 lb, 400 to 500 lb, Greater than 500 lb); Offering (Products and Accessories, Software and Solutions, and Services); Application (Fall Prevention, Pressure Injury Prevention, Patient Deterioration and Monitoring, and Others); End User (Hospitals, Clinics and Nursing Homes, Ambulatory Surgical Centers, Medical Laboratories, Long Term Care Centers, and Others), and Geography
Feb 2024
Heart Transplant Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Surgery Type (Orthotopic Heart Transplant and Heterotopic Heart Transplant), Type (Donor Live Heart and Artificial Hearts), End User (Hospitals, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Breath Analyzer Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Fuel Cell Technology, Semiconductor Sensor, Infrared Spectroscopy, and Others), Application (Drug Abuse Detection, Alcohol Detection, and Medical Applications), End User (Law Enforcement Agencies, Hospitals & Diagnostic Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Osteoarthritis Therapy Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type (TENS, Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others), Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals and Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography
Feb 2024
Surgical Navigation Systems Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Optical Navigation System, Electromagnetic Navigation System, Hybrid Navigation System, Fluoroscopy Navigation System, CT-Based Navigation System, and Others), Application (Orthopedic, ENT, Neurology, Dental, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography
Feb 2024
Teleradiology Services Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Deployment Type (Cloud-based, Web-based), Modality (MRI, CT-Scan, X-ray, Ultrasound, Others), Application (Musculoskeletal System, Gastroentrology, Cardiology, Oncology, Neurology, Others), End User (Hospitals and Clinics, Diagnostic and Imaging Centers, Others), and Geography
Feb 2024
Pedicle Screws Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Polyaxial Pedicle Screw Systems, Monoaxial Pedicle Screw Systems, and Other Pedicle Screw Systems), Application (Fracture, Spinal Tumor, Scoliosis, Failed Fusion, and Spondylitis), Surgery Type (Open Surgery and Minimally Invasive Surgery), End User (Hospitals, Ambulatory Surgical Centers, and Other End User), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Bovine Diagnostics Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products), Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Types], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users) and Geography
Get Free Sample For